Tracing the historical evolution of pediatric nephrologists who significantly contributed to the understanding and management of childhood renal disorders reveals that the beginning was in the 15th century with Cornelus Roelans' description of nephrotic syndrome, the narrative progresses through pivotal figures such as Theodore Zwinger, Richard Bright, and Emil Abderhalden, who laid foundational knowledge in the field. Notable contributions from Giovanni de Toni, Robert Debré, and Guido Fanconi further advanced understanding, leading to the recognition of the De Toni-Debré-Fanconi syndrome. Thereafter, advancements, included descriptions of syndromes by Charles Upton Lowe and Frederic Bartter. Despite progress, gaps remain in understanding the etiology of renal disorders, emphasizing the ongoing need for improved therapies.

Childhood renal disorders have been recognized as early as the 1400s. Cornelus Roelans (Figure-1) described a child with nephrotic syndrome in 1484, noting whole-body swelling [1].

Figure 1: Cornelis Roelans Van Mechelen (1450-1525) a Flemish Physician and Paediatrician.

In 1722, Theodore Zwinger (Figure-2) of Basel provided accurate descriptions of nephrotic syndrome, a significant chronic renal disorder in children. Notably, Zwinger correctly attributed the condition to the kidneys [2].

In 1827, Richard Bright (Figure-3) suggested that nephrotic syndrome comprises the triad of dropsy (generalized edema), albumin in urine (detected using the spoon and candle-heat coagulation), and renal disease.

In 1938, John D Lyttle emphasized a modern classification of childhood kidney disease, including acute glomerulonephritis, chronic glomerulonephritis, and nephrosis (nephrotic syndrome) [3].

Figure 2: Theodor Zwinger the Elder (August 1533-March 1588) A Swiss Physician from Basel.

Figure 3: Richard Bright (September 28, 1789-December 16, 1858), an English Physician Who Pioneered In the Research of Renal Disorders.

In 1903, Emil Abderhalden (Figure-4) described the first case of cystinosis [4]. In 1924, George Otto Emil Lignac (Figure-5), in his work "Disorders of cystine metabolism in children," provided a detailed description of the clinical manifestations of cystinosis, such as rickets, kidney disease, and growth retardation [5].

Figure 4: Emil Abderhalden (1877-1950), A Swiss Biochemist and Physiologist.

Figure 5: George Otto Emil Lignac (1891-1954), A Dutch Anatomist and Pathologist.

The complex disorder of renal tubular insufficiency has become known as "De Toni-Debré-Fanconi syndrome" after three pioneers of pediatric nephrology who contributed to its recognition and understanding [6-9].

In 1933, Giovanni de Toni (Figure-6) reported a girl with proximal tubular tubulopathy and associated neurological symptoms, including rickets, hypotonia, delayed development, and nystagmus [6].

Figure 6: Giovanni De Toni (March 3, 1895-January 8, 1973), an Italian Pediatrician.

In 1934, Robert Debré (Figure-7) reported a complex case of tubulopathy in an 11-year-old girl who had rickets associated with severe bone deformities (scoliosis) and multiple fractures [7].

In 1936, Guido Fanconi (Figure-8) reported children with hypophosphatemic rickets, acidosis, glycosuria, and excess organic acids in the urine, including some with cystinosis [8]. Therefore, childhood cystinosis has also been called Lignac-Fanconi syndrome.

Figure 7: La Vida De Robert Anselme Debre (1882-1978), A French Paediatrician.

Figure 8: Guido Fanconi (January 1, 1892-10 October 10, 1979), a Swiss Pediatrician.

In 1952, Charles Upton Lowe (Figure-9) and colleagues at Massachusetts General Hospital in Boston described an oculo-cerebro-renal syndrome involving three organ systems (eyes, brain, and kidney) [10].

In 1962, Frederic Bartter (Figure-10) and his colleagues described a syndrome resulting from a defect in the thick ascending limb of the loop of Henle, associated with hypokalemia, alkalosis, and normal to low blood pressure [11].

Pediatric nephrology is a relatively new discipline, emerging with increasing numbers of physicians and pediatricians interested in studying childhood renal diseases, particularly nephrotic syndrome.

Figure 9: Charles Upton Lowe (August 24, 1921-February 9, 2012), an American Pediatrician.

Figure 10: Frederic Crosby Bartter (September 10, 1914-May 5, 1983) Was An American Endocrinologist.

Treatment of children with chronic renal failure has evolved through modification of adult treatment principles, with dialysis reported as early as the 1950s [12-16].

However, there remains a gap in our understanding of the etiology of important childhood renal disorders such as nephrotic syndrome, and better, more convenient, or affordable therapies are still required for many childhood renal disorders, including refractory nephrotic syndrome and chronic renal failure.

Bibliometrics is the analysis of academic publications including citation analysis with aim of determining the impact or influence of papers and the academic who authored them. Increasingly, bibliometric assessments are being employed to evaluate the scientific productivity of academic leaders in various medical disciplines.

This study focuses on utilizing bibliometrics, particularly the H-index calculated via Google Scholar Citation analysis, to identify academic leaders in clinical pediatric nephrology.

The H-index calculated by the citation analysis tool of Google Scholar is one of the most important tools for the assessment of a physician’s academic leadership through measuring the influence of their academic productivity, and this measure is performed mostly through citation analysis of the published journal articles.

Google Scholar citation is the most commonly used tool for citation analysis, and you can search online for an academic citation analysis and H-index at this web site (Link below) [17-21].

Over 1000 Google Scholar Citation profiles were scrutinized in June 2024 to identify elite clinical pediatric nephrologists from 182 developing countries with an H-index of 20 or higher. The search aimed to provide a comprehensive overview of the global distribution of academic leadership in this specialized field in the developing world.

In May June, notable clinical pediatric nephrologists with H-indices of 20 or higher were identified from three countries, including Aamir Jalal Al-Mosawi from Iraq (H-index 23) [22], Neamatollah Ataei from Iran (H-index 21) [23], Mohammad Hossein Fallahzadeh from Iran (H-index 20) [24], and Wasiu A Olowu from Nigeria (H-index 20) [25].

Additionally, several countries boasted pediatric nephrologists with H-indices of 10 or higher, indicative of significant academic impact; including Girish C Bhatt from India (H-index 16) [26], Marcelo de Sousa Tavares from Brazil (H-index 13) [27], Domonkos Pap from Hungary (H-index 12) [28], and Seha Sayg?l? from Turkey (H-index 12) [29].

Conversely, some countries had profiles with lower H-indices, while others lacked pediatric psychiatrist profiles altogether.

There was pediatric psychiatrist profile with an H-index of 7 or less than 7 from six countries including Bangladesh, Israel, Japan, South Korea, and Sweden, Sri Lanka.

There was no pediatric nephrologist’s profile for many countries in the world including Afghanistan, Albania, Algeria, Andorra, Angola, Antigua & Barbuda, Argentina, Armenia, Austria, Azerbaijan, Bahamas, Bahrain, Barbados, Belarus, Belgium, Belize, Benin, Bhutan, Bolivia, Bosnia & Herzegovina, Botswana, Brunei, Bulgaria, Burkina Faso, Burundi, Cabo Verde, Cambodia, Cameroon, Central African republic, Chad, Chile, China, Colombia, Comoros, Congo democratic republic, Congo republic, Costa Rica, Ivory Coast, Croatia, Cuba, Cyprus, Czech republic, Denmark, Djibouti, Dominica, Dominican republic, Ecuador, Egypt, El Salvador, Equatorial Guinea, Eritrea, Estonia, Eswatini, Ethiopia, Fiji, Finland, Gabon, Gambia, Georgia, Ghana, Greece, Grenada, Guatemala, Guinea, Guinea-Bissau, Guyana, Haiti, Honduras, Iceland, Indonesia, Jamaica, Jordan, Kazakhstan, Kenya, Kiribati, Kuwait, Kyrgyzstan, Laos, Latvia, Lesotho, Liberia, Libya, Liechtenstein, Lithuania, Luxembourg, Madagascar, Malawi, Malaysia, Maldives, Mali, Malta, Marshall Islands, Mauritania, Mauritius, Mexico ,Micronesia, Moldova, Monaco, Mongolia, Montenegro, Morocco, Mozambique, Myanmar, Namibia, Nauru, Nepal, Netherlands, New Zealand, Nicaragua, Niger, North Korea, Macedonia, Norway, Oman, Pakistan, Palau, Palestine, Panama, Papua, New Guinea, Paraguay, Peru, Philippines, Poland, Portugal, Qatar, Romania, Russia, Rwanda, Saint Kitts & Nevis, Saint Lucia, Saint Vincent & the grenadines, Samoa, San Marino, São Tomé & Príncipe, Saudi Arabia, Senegal, Serbia, Seychelles, Sierra Leone, Singapore, Slovakia, Slovenia, Solomon Islands, Somalia, South Africa, South Sudan, Sudan, Suriname, Syria, Tajikistan, Tanzania, Thailand, Togo, Tonga, Trinidad & Tobago, Turkmenistan, Tuvalu, Uganda, Ukraine, United Arab Emirates, Uruguay, Uzbekistan, Vanuatu, Venezuela, Vietnam, Yemen, Zambia, Zimbabwe.

This bibliometric analysis sheds light on the distribution of academic leadership in clinical pediatric nephrology globally.

The identification of elite pediatric nephrologists underscores the significance of their contributions to the field. However, the varying levels of academic impact across different regions highlight opportunities for further research and collaboration to enhance scholarly productivity and knowledge dissemination.

By leveraging bibliometric tools like the H-index, stakeholders can better understand and support academic leaders in advancing pediatric nephrology care and research on a global scale.

This study showed notable clinical pediatric nephrologists with H-indices of 20 or higher from three countries, including Aamir Jalal Al-Mosawi from Iraq (H-index 23).

Aamir Jalal Al-Mosawi's pioneering work in pediatric nephrology has had a transformative impact on the diagnosis, management, and treatment outcomes of renal and urologic disorders in children. With a dedicated focus on enhancing the understanding of various conditions affecting pediatric renal health, Al-Mosawi established the first pediatric nephrology clinic and ward at the University Hospital in Al-Kadhimiyia during the early 2000s.

Aamir Jalal Al-Mosawi's groundbreaking contributions to pediatric nephrology have significantly impacted the understanding and management of renal and urologic disorders in Iraqi children.

His seminal research spanning over more than two decades, highlighted his pioneering studies on acute glomerulonephritis, chronic renal failure, nephropathic cystinosis, ocular abnormalities in chronic renal failure, renal tubular disorders, renal rickets, urolithiasis, oculo-cerebro-renal syndrome, congenital nephrotic syndrome, nonneurogenic neurogenic bladder, cryptorchidism, posthitis, congenital renal abnormalities, and rare syndromes associated with renal anomalies.

Al-Mosawi's comprehensive investigations have not only elucidated the epidemiology and etiology of these conditions but have also provided valuable insights into their clinical manifestations, diagnostic modalities, and evidence-based therapeutic approaches. His relentless pursuit of excellence in pediatric nephrology has significantly advanced the field, shaping clinical practice and improving the quality of care for pediatric patients with renal and urologic disorders in Iraq and beyond [30-52].

In his study published in Pediatric Nephrology in 2002, Al-Mosawi investigated the pattern of acute glomerulonephritis in Iraqi children, shedding light on the epidemiology and clinical presentation of this condition. By elucidating the characteristics and outcomes of acute glomerulonephritis in the pediatric population, Al-Mosawi's research has informed clinical practice and guided therapeutic interventions [30].

Al-Mosawi's research endeavors extended to chronic renal failure in Iraqi children, as evidenced by his published studies including the study published in Pediatric Nephrology in 2002. By elucidating the etiology and underlying factors contributing to chronic renal failure, Al-Mosawi provided valuable insights into the management and prevention of this debilitating condition, thereby improving the long-term prognosis for affected children [31,32,34,35[.

In 2006, he performed a study which aimed to shed light on the occurrence of nephropathic cystinosis among children in Iraq. Hopefully, the article provided valuable insights into the prevalence and characteristics of nephropathic cystinosis among Iraqi children, contributing to the broader understanding of this rare genetic disorder and facilitating better healthcare for affected individuals [35].

In his study published in The Open Urology & Nephrology Journal in 2010, Al-Mosawi explored the pattern of ocular abnormalities in children with chronic renal failure. By highlighting the ocular manifestations of renal impairment, Al-Mosawi underscored the importance of multidisciplinary care and comprehensive assessment in managing pediatric patients with chronic kidney disease [36].

Al-Mosawi's contributions to the understanding of renal tubular disorders and renal rickets are evident from his publications in Pediatric Oncall and Therapy (Clinical Practice). Through his research, Al-Mosawi identified novel associations and therapeutic approaches for conditions such as idiopathic hyperuricosuria, hypercalciuria, and infantile renal stone disease, as well as refractory vitamin D-resistant rickets. His innovative insights have expanded the armamentarium of treatment options for these complex disorders, offering hope to pediatric patients and their families [37, 38, 39].

Al-Mosawi's research repertoire also encompassed rare syndromes such as oculo-cerebro-renal syndrome and Bartter syndrome [40, 41].

Furthermore, his studies on progressive bilateral childhood urolithiasis of rare etiology have provided valuable insights into the diagnostic imaging and evidence-based therapeutic recommendations for pediatric patients with urolithiasis [42].

Al-Mosawi's work on congenital nephrotic syndrome sheds light on complex cases, such as the Finnish type with crescent formation. Through meticulous investigation and ultrasonographic assessments, he provided valuable insights into the diagnosis and management of this challenging condition, enriching the understanding of pediatric nephrologists worldwide [43].

Al-Mosawi's exploration of nonneurogenic neurogenic bladder in infants signifies his commitment to unraveling uncommon yet clinically significant urologic anomalies. His identification and discussion of this condition not only contribute to diagnostic accuracy but also prompt further research into its underlying mechanisms and therapeutic interventions [44].

Through epidemiological research and educational reviews, Al-Mosawi addresses the prevalence of cryptorchidism in Iraqi school children, emphasizing the importance of early detection and intervention. His comprehensive approach not only enhances awareness but also underscores the need for concerted efforts in pediatric urological care [45].

Al-Mosawi's documentation of posthitis in circumcised children highlights his keen clinical observations and dedication to expanding the literature on pediatric urology. By bringing attention to this previously unreported condition, he contributes to improved diagnostic accuracy and tailored management strategies [46].

Al-Mosawi's discovery of bilateral ectopic pelvic kidneys and their association with liver hemangioma, and the description of case forty-one of crossed unfused renal ectopia underscored his proficiency in recognizing rare anatomical variations and their clinical implications. His findings broaden the spectrum of renal anomalies, guiding clinicians in comprehensive patient assessment and care [47, 48].

Al-Mosawi's identification of autosomal dominant non-syndromic unilateral renal hypoplasia contributes to the expanding knowledge of renal developmental disorders. By delineating the genetic basis of this condition, he facilitates genetic counseling and underscores the importance of familial screening [49].

Al-Mosawi's report on the occurrence of non-syndromic unilateral renal hypoplasia and unilateral aplasia in siblings highlights familial predisposition to renal anomalies. His observations underscore the multifactorial etiology of renal developmental disorders, prompting further investigation into genetic and environmental factors [50].

Al-Mosawi's identification of Coffin-Siris syndrome in a patient with absent kidney underscores the intersection between genetics and renal abnormalities. His case report enriches the understanding of rare syndromes associated with renal anomalies, facilitating early recognition and multidisciplinary management [51].

Al-Mosawi's contribution to raising awareness of Mostyn Embrey syndrome through the documentation of unilateral renal agenesis highlights his commitment to disseminating knowledge and enhancing clinical recognition of rare genetic conditions. His efforts enable early diagnosis and tailored interventions for affected individuals [52].

Aamir Jalal Al-Mosawi's pioneering contributions to pediatric nephrology encompass a wide spectrum of renal and urologic disorders, ranging from congenital nephrotic syndrome to rare syndromes associated with renal anomalies. Through his innovative research, clinical acumen, and dedication to patient care, he has significantly advanced the field, leaving a lasting impact on pediatric nephrology in Iraq and beyond [30-52].

Dr. Al-Mosawi's early journey into the realm of pediatric nephrology began with a fervent commitment to unraveling the complexities of renal disorders affecting children. His commitment to advancing pediatric nephrology is evident in his seminal work on the treatment of childhood chronic renal failure with acacia gum and low protein diet which paved the way to the emergence of the concept of intestinal dialysis.

Intestinal dialysis, pioneered by Dr. Aamir Jalal Al-Mosawi, is a groundbreaking therapeutic approach for managing chronic renal failure. It utilizes acacia gum supplementation to facilitate dialysis within the intestinal tract, offering a less invasive alternative to conventional methods.

Al-Mosawi's research has demonstrated promising outcomes, particularly in pediatric patients with end-stage renal disease. Recent advancements in intestinal dialysis technology have further enhanced its clinical utility, with studies highlighting its practical implementation and nutritional implications. Through meticulous documentation of case studies, Al-Mosawi has underscored the diverse applications of intestinal dialysis and its potential to improve global renal health. In summary, intestinal dialysis represents a transformative advancement in renal care, offering hope to patients worldwide grappling with the burden of chronic renal failure [53-68].

Aamir Jalal Al-Mosawi has made significant strides in revolutionizing the treatment landscape for urolithiasis, particularly in pediatric cases. Through extensive research and clinical innovation, Al-Mosawi has introduced novel therapeutic approaches that have the potential to transform the management of this condition.

One of the noteworthy contributions of Al-Mosawi is his exploration of the adjunctive role of essential oil terpenes in the management of childhood urolithiasis. His studies shed light on the potential benefits of essential oil terpenes in alleviating the symptoms and complications associated with urolithiasis. By elucidating the mechanisms underlying the therapeutic effects of these compounds, Al-Mosawi has opened up new avenues for the development of complementary treatments for this condition.

In addition to his research on essential oil terpenes, Al-Mosawi has also identified new associations and therapeutic approaches for idiopathic hyperuricosuria, hypercalciuria, and infantile renal stone disease. Through his investigations, he has expanded our understanding of the underlying pathophysiology of these conditions and proposed innovative strategies for their management. His findings have not only advanced clinical practice but have also provided hope for patients grappling with these challenging disorders.

Furthermore, Al-Mosawi's work extends beyond the realm of traditional research publications. His contributions to textbooks, such as "Recent Progress in Medicinal Plants," highlight the importance of plant essential oil terpenes in renal disorders, consolidating his expertise in this field and disseminating knowledge to a wider audience of healthcare professionals and researchers.

Moreover, Al-Mosawi's commitment to sharing evidence-based therapeutic recommendations is evident in his publication "Progressive Bilateral Childhood Urolithiasis of Rare Etiology: Ultrasound Images and Evidence-Based Therapeutic Recommendations." This comprehensive resource not only presents compelling ultrasound images but also provides valuable insights into the management of a rare form of childhood urolithiasis, underscoring his dedication to advancing patient care through rigorous research and clinical expertise.

Aamir Jalal Al-Mosawi's contributions to the treatment of urolithiasis are truly pioneering. His innovative research, coupled with his commitment to evidence-based practice and knowledge dissemination, has significantly enriched our understanding of this complex condition and has the potential to improve the lives of countless individuals affected by urolithiasis. As we continue to grapple with the challenges posed by this condition, Al-Mosawi's work serves as a beacon of hope, inspiring future generations of clinicians and researchers to push the boundaries of medical science in pursuit of better treatments and outcomes for patients with urolithiasis [38, 42, 69, and 70.71].

This study underscores the historical evolution of pediatric nephrology and the contemporary utilization of bibliometrics to identify academic leaders in the field. The findings highlight both achievements and gaps in academic leadership across different countries, emphasizing the need for continued efforts to enhance the understanding and management of childhood renal disorders worldwide. By recognizing and supporting academic leaders, particularly in developing nations, advancements in pediatric nephrology can be further propelled, ultimately leading to improved therapies and outcomes for young patients with renal disorders.

This study showed notable clinical pediatric nephrologists with H-indices of 20 or higher from three countries, including Aamir Jalal Al-Mosawi from Iraq (H-index 23).

Aamir Jalal Al-Mosawi stands as a prominent figure in the field of pediatric nephrology, particularly in Iraq, where he spearheaded significant advancements and discoveries. Aamir Jalal Al-Mosawi's pioneering contributions to pediatric nephrology have significantly advanced the field, spanning epidemiological investigations, etiological elucidations, clinical characterizations, and therapeutic innovations.

Intestinal dialysis, a novel therapeutic approach in the management of chronic renal failure, has emerged as a promising avenue in renal care. Spearheaded by the groundbreaking work of Dr. Aamir Jalal Al-Mosawi, this innovative technique utilizes acacia gum supplementation to facilitate intestinal dialysis, offering a glimmer of hope to patients in resource-constrained settings.

By establishing a robust foundation of knowledge and evidence-based practices, Al-Mosawi has not only enhanced the standard of care for pediatric renal patients in Iraq but has also contributed to the global discourse on pediatric nephrology. His unwavering commitment to excellence serves as a beacon of inspiration for future generations of clinicians and researchers dedicated to improving pediatric renal health worldwide.

1. Roelans C. Liber de Aegritudinibus Infantium. München: Dr Verl der Mu nchner. 1484.
2. Zwinger T. Anasarca puerorum. In: Basel E, Thurnis JR. Editors. Paedioatreia Pract Curationem Puerorumque Morborum Puerilium etc 1974; 5: 659-66.
3. Lyttle JD. The Treatment of Acute Glomerulonephritis in Children. Bull NY Acad Med 1938; 14: 212-221.
4. Abderhalden E. Familiare cystindiathese. Z Physiol Chem 1903; 38: 557-561.
5. Lignac GOE. Uber storung des cystinstoffwechsels bei kindern. Deutsch Arch Klin Med 1924; 145: 139-150.
6. De Toni G. Remarks on the relations between renal rickets (renal dwarfism) and renal diabetes. Acta Paediatr. 1933; 16: 479-484.
7. Debre R, Marie J, Cleret F, Messimy R. Rachitisme tardif coexistant avec une nephrite chronique et une glycosurie. Arch Med Enfants. 1934; 37: 597-606.
8. Fanconi G. Der fruhinfantile nephrotisch-glycosurische zwergwuchs mit hypophosphatamischer rachitis. Jahrb Kinderheilk. 1936; 147: 299-304.
9. Debre R. Le syndrome du diabete rénal avec rachitisme osteomalacique incurable et troubles du developpement chez l'enfant [Renal diabetes syndrome with incurable osteoalacic rickets and developmental disorders in children]. Osterr Z Kinderheilkd Kinderfuersorge 1949; 3: 9-16.
10. Lowe CU, Terrey M, MacLachlan ea. Organic-aciduria decreased renal ammonia production, hydrophthalmos and mental retardation; a clinical entity. AMA Am J Dis Child 1952; 83: 164-184.
11. Bartter FC, Pronove P, Gill JR, Maccardle RC. Hyperplasia of the juxtaglomerular complex with hyperaldosteronism and hypokalemic alkalosis. A new syndrome. Am J Med. 1962; 33: 811-828.
12. Al-Mosawi AJ. The conservative management of nonterminal chronic renal failure. Therapy. 2006; 2: 305-306.
13. Al-Mosawi AJ. Continuous renal replacement in the developing world: Is there any alternative. Therapy. 2006; 3: 265-272.
14. Al-Mosawi AJ. Management of end-stage renal failure. Therapy. 2006; 2: 307-309. 2006.
15. Al-Mosawi AJ. The Management of Childhood Chronic Renal Failure in the Developing World. Section on international child health: American Academy of Pediatrics Newsletter. Fall. 2008:17-19.
16. Holliday MA. Dialysis in pediatrics, including use of the artificial kidney. Pediatrics 1958; 22: 418-421.
17. Al-Mosawi AJ. Scientific Publication Productivity and Research Activities of Iraqi Pediatricians in the Field of Pediatric Nephrology: A Bibliometric Analysis to Identify Pioneers. Advancements in Journal of Urology and Nephrology. 2019; 1: 1-10.
18. Al-Mosawi AJ. The H-index: An educational article. Clinical Sciences and Clinical Research. 2023; 2: 1-15.
19. Al-Mosawi AJ. A corrected H-index for academic leadership determination .1st ed., Saarbrücken; LAP Lambert Academic Publishing: 2020.
20. Al-Mosawi AJ. The H-index: What academics need to know? LAP LAMBERT Academic Publishing: 2023; 02: 16.
21. Al-Mosawi AJ. ResearchGate RG score in the determination of modern pioneers of medicine. LAP LAMBERT Academic Publishing: 2021.
22. Al-Mosawi AJ. The pattern of acute glomerulonephritis in 47 Iraqi children. Pediatr Nephrol. 2002; 17: 74-75.
23. Al-Mosawi AJ. The etiology of chronic renal failure in 54 Iraqi children. Pediatr Nephrol 2002; 17: 463-464.
24. Al-Mosawi AJ. The Etiology of chronic renal failure in a sample of Iraqi patients: Lower incidence of diabetes and hypertension related renal failure. The New Iraqi J Med. 2006; 2: 27-30.
25. Al-Mosawi AJ. Chronic renal failure in Iraqi children: 14 year experience of a single center. J Nephr Renal Transplantation. 2008; 1: 32-40
26. Al-Mosawi AJ. Symptomatic Childhood Uremic Pericardial Effusion: An Echocardiography Image. SunKrist Heart Failure and Cardiology Insights. 2020; 2: 1-3.
27. Al-Mosawi AJ. Nephropathic cystinosis in Iraqi children. The New Iraqi J Med. 2006; 2: 22-225.
28. Al-Mosawi AJ. The pattern of ocular abnormalities in childhood chronic renal failure. The Open Urology & Nephrology Journal. 2010; 3: 1-3.
29. AL Mosawi AJ .Spectrum of Renal Tubular Disorders in Iraqi Children. Pediatric Oncall. 2008; 5:107-109.
30. 3Al-Mosawi AJ. Idiopathic hyperuricosuria, hypercalciuria and infantile renal stone disease: new association and therapeutic approach. Therapy (Clinical practice) 2006; 3: 755-757.
31. Al-Mosawi AJ. Experience with refractory vitamin D-resistant rickets and non-17α alkyl testosterone derivative anabolic agent. Therapy (Clinical practice). 2005; 2: 91-94.
32. Al-Mosawi AJ. Oculo-cerebro-renal syndrome phenotype in four Iraqi children. J Pediatric Neurology. 2007; 5: 75-78.
33. Al-Mosawi AJ. Pediatric Bartter syndrome: The therapeutic challenge. Archives of Clinical Nephrology. 2020; 6: 5-9.
34. Al-Mosawi AJ. Progressive Bilateral Childhood Urolithiasis of Rare Etiology: Ultrasound Images and Evidence-Based Therapeutic Recommendations. SunKrist Nephrology and Urology Journal. 2021; 2: 1-5.
35. Al-Mosawi AJ. Congenital Nephrotic Syndrome of the Finnish Type with Crescent Formation: A Challenging Case and Ultrasonographic Findings. Universal Journal of Radiology and Nuclear Medicine. 2020; 1: 1-4.
36. Al-Mosawi AJ. Identification of nonneurogenic neurogenic bladder in infants. Urology 2007; 70: 355-356.
37. Al-Mosawi AJ. Prevalence of cryptorchidism in Iraqi school children and an educational review. Biomedical and Biotechnological Sciences. 2022; 1: 1-6.
38. Al-Mosawi AJ. Posthitis in Circumcised Child: A Condition Not Previously Reported in the Literature. Archives of Urology. 2020; 3: 16-18.
39. Al-Mosawi AJ. Bilateral ectopic pelvic kidneys: The novel association with liver hemangioma. Journal of Radiology Research and Diagnostic Imaging. 2023; 1: 1-4.
40. Al-Mosawi AJ. The Case Forty-One of Crossed Unfused Renal Ectopia. International Journal of Recent Innovations in Medicine and Clinical Research. 2020; 2: 17-21.
41. Al-Mosawi AJ. Autosomal dominant non-syndromic unilateral renal hypoplasia: A condition not previously reported in the literature. International Journal of Radiology Research. 2020; 2: 18-19.
42. Al-Mosawi AJ. The novel occurrence of non-syndromic unilateral renal hypoplasia and unilateral aplasia in two brothers. Clinical Sciences and Clinical Research. 2023; 2: 1-3.
43. Al-Mosawi AJ. Genetic drift. Letter from Baghdad: Coffin-Siris syndrome in a girl with absent kidney Am J Med Genet A. 2006; 140: 1789-1790.
44. Al-Mosawi AJ. Unilateral Renal Agenesis and the Awareness of Mostyn Embrey Syndrome. Journal of Renal Medicine. 2017; 1: 1-4.
45. Al-Mosawi AJ. The challenge of chronic renal failure in the developing world: possible use of acacia gum. Pediatr Nephrol. 2002; 17: 390-391.
46. Al-Mosawi AJ. Acacia gum supplementation of a low-protein diet in children with end-stage renal disease. Pediatr Nephrol. 2004; 19: 1156-1159.
47. Al-Mosawi AJ. The use of acacia gum in end stage renal failure. J Trop Pediatr. 2007; 53: 362-365.
48. Al-Mosawi AJ. Six-year dialysis freedom in end-stage renal disease. Clin Exp Nephrol. 2009; 13: 494-500.
49. Al-Mosawi AJ. Continuous renal replacement in the developing world: Is there any alternative. Therapy. 2006; 3: 265-272.
50. Al-Mosawi AJ. A step towards the introduction of acacia gum as a medicine. Therapy. 2006; 2: 313-314.
51. Al-Mosawi AJ. Dietary dialysis with acacia gum: Intestinal dialysis technology. Advancements in Journal of Urology and Nephrology. 2019; 2: 1-8.
52. Al-Mosawi AJ. A New Dietary Therapy for Chronic Renal Failure: Intestinal Dialysis Technology. Journal of medical and surgical urology. 2020; 1: 8-16.
53. Al-Mosawi AJ. History of Medicine: The Emergence of Intestinal Dialysis. SunKrist Nephrology and Urology Journal. 2020; 2: 1-8.
54. Al-Mosawi AJ. Intestinal (Dietary) Dialysis: A Practical Nutritional Guide. J Urology res. 2020; 7: 1118.
55. Al-Mosawi AJ. Intestinal dialysis in a uremic patient with diabetic nephropathy: A challenging case and a unique experience. Journal of Pharmaceutical Research and Development. 2020; 1: 1-4.
56. Al-Mosawi AJ. The early treatment of a bodybuilder with symptomatic chronic renal failure with intestinal dialysis: A new recommendation for intestinal dialysis enhancement. J Urology Nephrology Stud. 2022; 3: 308-311.
57. Al-Mosawi AJ. Another patient with symptomatic uremia treated with intestinal dialysis: An educational article. International Journal of Medical Sciences and Academic Research. 2021; 2: 1-7.
58. Al-Mosawi AJ. Another patient with symptomatic uremia treated with intestinal dialysis: An educational article. Archives of Urology. 2023; 5: 1-6.
59. Al-Mosawi AJ. The Rare Association of Adult Polycystic Kidney with Hearing Impairment and Further Experience with Intestinal Dialysis: An Educational Article. International J Clinical Nephr. 2023; 5: 1-9. 68
60. Al-Mosawi AJ. Intestinal Dialysis Research Progress and the Early Treatment of a Non-Diabetic Patient with Symptomatic Uremia and Fatty Liver with Intestinal Dialysis: the Practice of Evidence-Based Medicine. Journal of Biomedical Sciences and Biotechnology Research. 2024; 2: 1-4.
61. Al-Mosawi AJ. Essential oil terpenes: adjunctive role in the management of childhood urolithiasis J Med Food. 2010; 13: 247-250.
62. Al-Mosawi AJ. A possible role of essential oil terpenes in the management of childhood urolithiasis. Therapy. 2005; 2: 243-247.
63. Al-Mosawi AJ. Role of plant essential oil terpenes in renal disorders. In: JN. Govil and Sanjib Bhattacharya (Ed). Recent Progress in Medicinal Plants sEssential Oils. Studium Press. 2023; 36.